HUTCHMED (China) Limited (HKG:0013)
19.42
+0.34 (1.78%)
Apr 8, 2025, 1:45 PM HKT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
2.70M HKD
Profits / Employee
161.82K HKD
Market Cap
16.50B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Innovent Biologics | 5,659 |
Akeso | 2,778 |
Alibaba Health Information Technology | 1,435 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
HUTCHMED (China) News
- 17 days ago - HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma - GlobeNewsWire
- 18 days ago - Intended Retirement of Independent Non-executive Directors and changes of composition of board committees - GlobeNewsWire
- 19 days ago - US pharma restrictions won't affect Hutchmed operations, says CEO - CNBC
- 19 days ago - HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025 - GlobeNewsWire
- 19 days ago - Hutchmed spikes after cancer trial win despite 2024 revenue miss - Seeking Alpha
- 19 days ago - HUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Hutchmed's Oncology Revenue Hits $271.5 Million, Rising 65% On Fruzaqla Strength - Benzinga
- 19 days ago - Hutchmed's Oncology Revenue Hits $271.5 Million, Rising 65% On Fruzaqla Strength - Benzinga